Carlos Arteaga
Medical Oncology · Dallas, TXNPI 1902980014
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $64,026 of the $66,183 with a category attached, or 96.7%. 11 manufacturers reported payments, led by Radius Health, Inc. at 34.0% of the total. Reporting peaked in 2019 at $54,618 and has fallen 100.0% since, to $22 in 2024.
Across 39 payments — averaging $1697.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Radius Health, Inc.$23K
- Novartis$17K
- Daiichi Sankyo Inc.$14K
- Sanofi$4K
- AstraZeneca$3K
- Eli Lilly$2K
- plus $2K from 5 others
Across 16 payments — averaging $46,557 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$330K
- Radius Health, Inc.$224K
- Eli Lilly$173K
- Sanofi US Services Inc.$10K
- Novartis$8K
What the payments were for
- Consulting fees$64,02697%
- Travel & lodging$1,4702%
- Food & beverage$6751%
- Education$120%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Radius Health, Inc. | 3 | $22,500 |
| Novartis | 6 | $17,022 |
| Daiichi Sankyo Inc. | 15 | $14,391 |
| Sanofi | 2 | $4,266 |
| AstraZeneca | 1 | $3,450 |
| Eli Lilly | 6 | $2,173 |
| Clovis Oncology, Inc. | 2 | $1,613 |
| Astrazeneca UK Limited | 1 | $685 |
| Puma Biotechnology, Inc. | 1 | $50 |
| Tempus AI, Inc | 1 | $22 |
| Gilead | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$66,183 in reported general payments places this provider in the 80th percentile of 495 medical oncology providers in Texas.
Other medical oncology in Dallas
- Moshe LevyDallas$5.1M
- Andrew WhiteleyDallas$1.7M
- Eric NadlerDallas$1.6M
- Joyce O'ShaughnessyDallas$1.3M
- Ronan KellyDallas$1.1M
- Thomas HutsonDallas$944K
- Heather McArthurDallas$314K
- Tian ZhangDallas$286K
- Micah BurchDallas$221K
- David JohnsonDallas$212K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.